ORKA

Oruka Therapeutics, Inc.$72.70-3.69 (-4.83%)

Prev Close$76.39·MCap$2.58B·P/E—·Vol2.34M·Yield0.28%

▲

Buys (12M)

$0.00

▼

Sells (12M)

$2.35M

◆

Net Activity

Net Seller

$2.35M

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Oruka Therapeutics, Inc. (ORKA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 11 insider sales totaling $2.35M. The most recent insider transaction was by Goncalves Joana (officer: Chief Medical Officer), who sold $462.8K worth of shares on Apr 15, 2026. Oruka Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.58B.

ORKA Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 15, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	7,000	$66.12	$462.8K	36,150
Mar 17, 2026	Quinlan Paul T	officer: General Counsel	Sell	733	$41.30	$30.3K	31,767
Mar 17, 2026	Agarwal Arjun	officer: Senior Vice President, Finance	Sell	395	$41.30	$16.3K	18,863
Mar 17, 2026	Klein Lawrence Otto	director, officer: Chief Executive Officer	Sell	1,729	$41.30	$71.4K	927,309
Mar 17, 2026	Sandler Laura Lee	officer: Chief Operating Officer	Sell	600	$41.30	$24.8K	236,984
Mar 17, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	7,641	$40.91	$312.6K	38,097
Mar 2, 2026	Sandler Laura Lee	officer: Chief Operating Officer	Sell	5,000	$33.56	$167.8K	240,259
Feb 17, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	14,000	$32.37	$453.1K	34,954-29%
Jan 16, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	7,000	$31.81	$222.7K	4,137-63%
Jan 2, 2026	Sandler Laura Lee	Chief Operating Officer	Sell	13,000	$28.52	$370.8K	209,336
Dec 19, 2025	Goncalves Joana	Chief Medical Officer	Sell	7,000	$30.61	$214.3K	7,877-47%
Feb 27, 2025	Venrock Healthcare Capital Partners III, L.P.		Buy	122,882	$11.45	$1.41M	4,148,428
May 25, 2022	Funicular Fund, LP		Buy	85,262	$2.32	$197.4K	2,580,452
May 20, 2022	Funicular Fund, LP		Buy	13,073	$2.30	$30.1K	2,495,190
May 16, 2022	Funicular Fund, LP		Buy	84,836	$2.29	$194.1K	2,482,117
May 11, 2022	Funicular Fund, LP		Buy	45,575	$2.28	$104.1K	2,397,281
May 9, 2022	Funicular Fund, LP		Buy	124,122	$2.28	$282.6K	2,351,706
May 2, 2022	Funicular Fund, LP		Buy	33,614	$2.31	$77.7K	2,227,584
Apr 27, 2022	Funicular Fund, LP		Buy	13,751	$2.29	$31.5K	2,193,970
Apr 20, 2022	Funicular Fund, LP		Buy	9,119	$2.31	$21.1K	2,180,219
Apr 14, 2022	Funicular Fund, LP		Buy	17,410	$2.33	$40.5K	2,171,100
Apr 12, 2022	Funicular Fund, LP		Buy	104,713	$2.32	$242.7K	2,153,690
Apr 7, 2022	Funicular Fund, LP		Buy	103,984	$2.31	$239.8K	2,048,977
Apr 4, 2022	Funicular Fund, LP		Buy	122,342	$2.26	$276.3K	1,944,993
Nov 23, 2021	Ozeroff Christopher David	S.V.P., General Counsel	Buy	50,000	$2.26	$113.2K	50,970New Position
May 13, 2021	CONWAY ROBERT E	Director	Buy	10,000	$3.19	$31.9K	50,000+25%
May 6, 2021	CONWAY ROBERT E	Director	Buy	10,000	$3.23	$32.3K	40,000+33%

ORKA Insider Buying Activity

The following table shows recent insider purchases of Oruka Therapeutics, Inc. (ORKA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Feb 27, 2025	Venrock Healthcare Capital Partners III, L.P.		Buy	122,882	$11.45	$1.41M	4,148,428
May 25, 2022	Funicular Fund, LP		Buy	85,262	$2.32	$197.4K	2,580,452
May 20, 2022	Funicular Fund, LP		Buy	13,073	$2.30	$30.1K	2,495,190
May 16, 2022	Funicular Fund, LP		Buy	84,836	$2.29	$194.1K	2,482,117
May 11, 2022	Funicular Fund, LP		Buy	45,575	$2.28	$104.1K	2,397,281
May 9, 2022	Funicular Fund, LP		Buy	124,122	$2.28	$282.6K	2,351,706
May 2, 2022	Funicular Fund, LP		Buy	33,614	$2.31	$77.7K	2,227,584
Apr 27, 2022	Funicular Fund, LP		Buy	13,751	$2.29	$31.5K	2,193,970
Apr 20, 2022	Funicular Fund, LP		Buy	9,119	$2.31	$21.1K	2,180,219
Apr 14, 2022	Funicular Fund, LP		Buy	17,410	$2.33	$40.5K	2,171,100
Apr 12, 2022	Funicular Fund, LP		Buy	104,713	$2.32	$242.7K	2,153,690
Apr 7, 2022	Funicular Fund, LP		Buy	103,984	$2.31	$239.8K	2,048,977
Apr 4, 2022	Funicular Fund, LP		Buy	122,342	$2.26	$276.3K	1,944,993
Nov 23, 2021	Ozeroff Christopher David	S.V.P., General Counsel	Buy	50,000	$2.26	$113.2K	50,970New Position
May 13, 2021	CONWAY ROBERT E	Director	Buy	10,000	$3.19	$31.9K	50,000+25%
May 6, 2021	CONWAY ROBERT E	Director	Buy	10,000	$3.23	$32.3K	40,000+33%

ORKA Insider Selling Activity

The following table shows recent insider sales of Oruka Therapeutics, Inc. (ORKA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Apr 15, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	7,000	$66.12	$462.8K	36,150
Mar 17, 2026	Quinlan Paul T	officer: General Counsel	Sell	733	$41.30	$30.3K	31,767
Mar 17, 2026	Agarwal Arjun	officer: Senior Vice President, Finance	Sell	395	$41.30	$16.3K	18,863
Mar 17, 2026	Klein Lawrence Otto	director, officer: Chief Executive Officer	Sell	1,729	$41.30	$71.4K	927,309
Mar 17, 2026	Sandler Laura Lee	officer: Chief Operating Officer	Sell	600	$41.30	$24.8K	236,984
Mar 17, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	7,641	$40.91	$312.6K	38,097
Mar 2, 2026	Sandler Laura Lee	officer: Chief Operating Officer	Sell	5,000	$33.56	$167.8K	240,259
Feb 17, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	14,000	$32.37	$453.1K	34,954-29%
Jan 16, 2026	Goncalves Joana	officer: Chief Medical Officer	Sell	7,000	$31.81	$222.7K	4,137-63%
Jan 2, 2026	Sandler Laura Lee	Chief Operating Officer	Sell	13,000	$28.52	$370.8K	209,336
Dec 19, 2025	Goncalves Joana	Chief Medical Officer	Sell	7,000	$30.61	$214.3K	7,877-47%